NPPB and coronary artery disorder: We followed 964 patients with CAD, testing a panel of biomarkers that comprised galectin-3 and monocyte chemoattractant protein-1 (MCP-1), both involved in inflammation and atherothrombosis, as well as the inactive N-terminal fragment of brain natriuretic peptide (NT-proBNP), which is related to heart failure.